MOLN:NASDAQ
Molecular Partners AG
$4.35
arrow_upward
+6.88%(+0.28) 1D
Sep 3, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
$4.35
High
$4.35
Low
$4.35
Mkt. cap
180.27M
Avg. vol.
1.09K
Volume
0.00
52-wk high
$5.36
52-wk low
$3.53
EPS
-$1.69
Beta
1.02
Shares outstanding
40.38M
No. of employees
134
Open
$4.35
High
$4.35
Low
$4.35
Mkt. cap
180.27M
Avg. vol.
1.09K
Volume
0.00
52-wk high
$5.36
52-wk low
$3.53
EPS
-$1.69
Beta
1.02
Shares outstanding
40.38M
No. of employees
134
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 weeks ago
MOLN Q4 2025 Earnings: Narrower-Than-Expected Loss Points to Cost Discipline - Financial Summary
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG